Celcuity Inc. Files 2024 10-K Report

Ticker: CELC · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1603454

Sentiment: neutral

Topics: 10-K, financials, medical-laboratories

TL;DR

Celcuity Inc. 2024 10-K filed. Financials for 2024, 2023, 2022 detailed. #investing

AI Summary

Celcuity Inc. filed its 2024 10-K report on March 31, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, based in Minneapolis, MN, operates in the medical laboratories sector. The filing provides financial data for the years 2024, 2023, and 2022, including details on common stock, preferred stock, additional paid-in capital, and retained earnings.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Celcuity Inc.'s financial health and operational performance for the fiscal year 2024, enabling informed investment decisions.

Risk Assessment

Risk Level: medium — As a medical laboratories company, Celcuity Inc. is subject to regulatory changes, market competition, and the inherent risks of the healthcare industry.

Key Numbers

Key Players & Entities

FAQ

What is Celcuity Inc.'s primary business activity?

Celcuity Inc. operates in the SERVICES-MEDICAL LABORATORIES sector, with SIC code 8071.

When was the 10-K report filed?

The 10-K report was filed on March 31, 2025.

What is the company's principal place of business?

The company's business address is 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN 55446.

What fiscal periods are covered by the financial data in this filing?

The filing includes financial data for the fiscal years ending December 31, 2024, December 31, 2023, and December 31, 2022.

What is the SEC file number for Celcuity Inc.?

The SEC file number for Celcuity Inc. is 001-38207.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Celcuity Inc. (CELC).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing